Bleil Lynn Dorsey has filed 6 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 20414 shares of AMICUS THERAPEUTICS, INC. ($FOLD) on June 05, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 5, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Bleil Lynn Dorsey | Not found | A | Common Stock | 20414 | $0.00 | 113,941.0000 | 300,116,081 | 21.83% | 0.01% |
| June 5, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Bleil Lynn Dorsey | Not found | A | Stock Options (right to buy) | 74872 | $0.00 | 74,872.0000 | 300,116,081 | 9999.99% | 0.02% |
| June 6, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Bleil Lynn Dorsey | Not found | A | Common Stock | 11847 | $0.00 | 93,527.0000 | 295,164,515 | 14.50% | 0.00% |
| June 6, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Bleil Lynn Dorsey | Not found | A | Stock Options (right to buy) | 42467 | $0.00 | 42,467.0000 | 295,164,515 | 9999.99% | 0.01% |
| June 8, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Bleil Lynn Dorsey | Director | A | Common Stock | 8584 | $0.00 | 81,680.0000 | 289,057,198 | 11.74% | 0.00% |
| June 8, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Bleil Lynn Dorsey | Director | A | Stock Options (right to buy) | 30474 | $0.00 | 30,474.0000 | 289,057,198 | 9999.99% | 0.01% |